Inflammatory breast cancer: the disease, the biology, the treatment. - Wikidata - awgldk - TriplyDB

Inflammatory breast cancer: the disease, the biology, the treatment.

Inflammatory breast cancer: the disease, the biology, the treatment.

http://www.wikidata.org/entity/Q37801500

about

Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: case report and literature review Inflammatory breast cancer: New factors contribute to disease etiology: A review Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine In vivo lymphatic imaging of a human inflammatory breast cancer model.Microfluidic cytometric analysis of cancer cell transportability and invasiveness Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States.Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.Immunologic targeting of FOXP3 in inflammatory breast cancer cells.Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models.Inflammatory breast cancer (IBC): clues for targeted therapies Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Circulating tumor cells in newly diagnosed inflammatory breast cancer.Prognostic significance of tumour stroma ratio in inflammatory breast cancer.Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy.Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization.A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoides Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene.Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.Radiological and clinical features of adult non-puerperal mastitis Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy.

P2860

Q21245603-F72ED3FF-AA6D-40C2-B379-47E830E1C357 Q27027856-E9344062-2F0D-47BB-B276-7B95443B248B Q28554790-7F77C149-42D9-40D4-907A-8D8EBD694130 Q30596741-7863C52E-F9B5-40BE-A2CE-6C317C09BD7B Q30665958-41A5A9AC-E311-4349-A8A0-8AF531D2B534 Q33616254-F947ABC3-9373-48FF-B5CE-EB6C63CA40B0 Q33618285-4C924582-9B83-43CB-A566-FCD99F268D93 Q33760216-06BFA557-02C1-404E-BCC0-186C5974B10D Q33770856-04A6FDC3-6216-48FE-82E9-F6F10739AE05 Q33829270-58632CA2-72AB-4FA3-A132-AE1B2556C5BF Q34292730-97FA65C7-BBA8-4972-9979-3119E5487CBF Q34558393-7B1F3AA0-6BA0-466E-9BE2-FA34F7F243DC Q34589568-B63ABFA2-9C61-4848-97E7-D4D64A38AC92 Q34612111-040C26DB-B3B0-4F45-B6C6-7DB7CAB42999 Q34754098-6B8EFC07-7D63-46D6-AE45-8D240EC781D2 Q34918360-776DF56A-DCCA-4019-9D20-7169FB7EA5CA Q35052773-7A22DC0B-E370-4564-A989-26436A1EDD4D Q35103001-18BE1792-8364-4188-90B4-2C600CB9B0A8 Q35214370-829A254C-77A4-4491-9E19-0C3E4579BB32 Q35576639-7F820A3A-B7CF-4D31-8A80-9BEC508E0649 Q35580748-3E07A14F-4720-4284-BD06-29184E4C9BE9 Q35619119-BCEE1753-2493-4A12-8E6F-CB1F01F2EB10 Q35825566-EAB3257C-1915-4586-B700-D094F84FE0F3 Q35829855-92EDD046-3EDD-4674-B0D6-D28974C43500 Q35869752-5F5BCCD4-4DBB-403A-9984-0CEE67408C93 Q35890623-25315F27-61DE-448B-B40F-5D2186D4E28C Q35955369-D30F2B96-927D-482D-8745-EE6F4EB9FFD1 Q35981180-798D3E4F-7913-4018-B0D8-5438EA90AED3 Q35985276-79441690-F3D9-4209-8A19-14F9F72AD191 Q35999539-60E8971A-6BC8-421A-ABF9-B0274C9A76A2 Q36243278-5A487A27-4055-4A06-9653-812697A72873 Q36286773-1F3F3318-2E91-4AC8-A479-367D8CBA8B49 Q36528656-3A99D7F1-E7C6-4228-B625-82C6680D088F Q36583979-E05C0594-3C22-4FCC-B3BB-1267FA268550 Q36587844-3D30DEF2-F535-46EE-9CA1-AE04406700EF Q36599823-E3EA70CA-E528-4298-BBA3-F344358DE432 Q36725203-186005F0-D278-4832-961F-43AF7DA8AD83 Q36751784-81F8968F-24A9-423B-85A3-FEFB4C237A82 Q36793606-61180A50-AC6A-46F5-9C16-67838737FA02 Q36925197-67A3D967-7F6B-4017-96E4-396DEB84BD54

P2860

Inflammatory breast cancer: the disease, the biology, the treatment.

http://www.wikidata.org/entity/Q37801500

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inflammatory breast cancer: the disease, the biology, the treatment.

@en

Inflammatory breast cancer: the disease, the biology, the treatment.

@nl

type

label

Inflammatory breast cancer: the disease, the biology, the treatment.

@en

Inflammatory breast cancer: the disease, the biology, the treatment.

@nl

prefLabel

Inflammatory breast cancer: the disease, the biology, the treatment.

@en

Inflammatory breast cancer: the disease, the biology, the treatment.

@nl

P1433

Q37801500-5DAD8E1A-8A24-4911-9D5F-C6F920770D1F

P1476

Q37801500-9AC34FCB-831A-483C-AF3F-CFA3003AF8EF

P2093

Q37801500-001E88C4-39FA-48A6-B7C6-FF674A0DE6C2

Q37801500-07FC8D77-F53D-4FA1-A684-9F98694DE025

Q37801500-42E8FD74-7232-44A9-9964-4062DEFAFCA9

Q37801500-5ED0813F-14BD-46F6-8554-DF7EDB5FB712

Q37801500-5F26829A-EDE8-4D30-928C-5296EDD29D0B

Q37801500-67C59E2A-F2CE-4C6B-8D83-5857D0171685

Q37801500-6A0674B4-1966-432E-8E2B-AEEB63FA9BA7

Q37801500-794CF7AC-076D-465B-A8B2-44F3207E6C04

Q37801500-815102FF-8EA7-4334-A18D-703F59E56025

Q37801500-A9E07159-086F-46D7-83F4-D577869E5B08

P2860

Q37801500-1B6B6571-1E65-4282-A8A9-292C6B87C2F7

Q37801500-382682E2-055D-4F4A-989A-C74BEB002219

Q37801500-39EF5E99-A669-44ED-8893-D8FF60F4E0AA

Q37801500-7082F43A-D07E-4018-857E-EB514AA434EC

Q37801500-F65D7466-D0FC-467F-B90F-FC5A63021E9A

P304

Q37801500-7EB3147C-189F-4005-82AC-DC6EF0D44233

P31

Q37801500-7131C6D5-C457-43F6-9575-72D7CEA9D3EA

P356

Q37801500-154A7761-4605-4E2A-9F6C-EEE7A5A0FE0B

P407

Q37801500-78D1F523-0B6B-4845-B351-0BBCE83338A1

P433

Q37801500-8A0197C4-96B3-45F6-8E49-4C01B730F02B

P478

Q37801500-1C2DFAC0-DCE6-4340-8544-EE49433CF553

P50

Q37801500-07583ED1-444A-4AC2-BA2A-B693F1105202

Q37801500-188EB002-5A7D-4C0B-BC7B-79B10AA4DC8B

P577

Q37801500-1E66A46B-07F6-4332-9A2F-91BE51B96099

P5875

Q37801500-5FBC408E-A22A-48A8-9B75-C8C82C27226F

P698

Q37801500-57BD046B-3BB0-4742-A29A-28E51A194D6D

P921

Q37801500-62CC0E81-AD8C-425E-BE83-34B2E56C9528

P356

P1433

P1476

Inflammatory breast cancer: the disease, the biology, the treatment.

@en

P2093

Anthony Lucci

http://www.w3.org/2001/XMLSchema#string

Audrey N Player

http://www.w3.org/2001/XMLSchema#string

Fredika M Robertson

http://www.w3.org/2001/XMLSchema#string

Hideko Yamauchi

http://www.w3.org/2001/XMLSchema#string

Huong Le-Petross

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

Melissa Bondy

http://www.w3.org/2001/XMLSchema#string

Naoto T Ueno

http://www.w3.org/2001/XMLSchema#string

Samira Kamrudin

http://www.w3.org/2001/XMLSchema#string

Sanford H Barsky

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

Ten-year outcome after combined modality therapy for inflammatory breast cancer.

Lighting up tumors with receptor-specific optical molecular probes.

Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation.

P304

351-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3322/CAAC.20082

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Wendy A Woodward

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47499971

http://www.w3.org/2001/XMLSchema#string

P698

20959401

http://www.w3.org/2001/XMLSchema#string

P921